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incidence of urethane induced lung tumours bears a relationship to the incidence
of spontaneous lung tumours in various inbred lines of mice. In this event,
pentose nucleotides would be expected to have an inhibitory action on the
formation of spontaneous lung tumours.
SUMMARY.
1. Pentose nucleotides, when injected into mice receiving treatment with
urethane, decreases almost by half the number of lung tumours caused by it.
2. Possible modes of action of urethane as a carcinogen for lung were dis-
cussed, especially with respect to its leucopaenic action.
All expenses in connection with this work were borne by the British Empire
Cancer Campaign.
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THE idea of somatic mutation as an explanation for the origin of cancer has
had a long and interesting history. Its original use as an interpretation ofcancer
is usually associated with the names of Murray and of Boveri. These men
arrived at the somatic mutation conclusion from different fields, Murray from
experimental cancer research, and Boveri from his classical observations in
experimental embryology. A -good description of the origin of cancer was
formulated by Murray (1908). At that time he stated: "The existence of such
tumours, the biological characters of which are retained through long periods of
propagation, shows that the cellular transformation which initiates carcinomatous
growth may take place in varying degrees. The impress which the cells receive,
at this time, while permitting ofgreat histological variations in their descendants,
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colours permanently their whole biological behaviour. This biological alteration
is of such a kind that the cells are able to take up nourishment, increase in size
and multiply indefinitely. They acquire an individuality and powers ofresistance
to injurious agencies superior to those of normal tissue elements."
Boveri's idea on the nature of the origin of cancer stemmed from his obser-
vations on atypical mitoses. He had suggested the possibility that by this means
an unequal distribution ofthe chromosomes would ensue and thus lead to uncon-
trolled growth. He was loath to expand upon this concept until Aichel
(1911), using Boveri's own observations on the development of the sea urchin
egg, arrived at the conclusion that a malignant tumour was caused by a fusion
of a tissue cell with a leucocyte. Boveri's concept has not received wide recog-
nition. The essential feature of the idea is expressed in his own words (Boveri,
1929): "The essence of my theory is not abnormal mitosis, but in general, a
definite abnormal chromosome-complex. However this may arise, the result
would always be a definite tumour. Beside the multipolar mitoses, which might
depend either on a simultaneous multidivision of the centrosome or on distorting
the parallelism between the division of the centrosome and the cell-division,
asymmetrical mitosis should be chiefly considered for the origin of tumours.
Indeed, according to analogy with certain occurrences in sea urchins, these would
depend on a lack in certain chromosomes of the power to divide; this would
result far more surely in tumour than would multipolar mitoses, which depend
on chance for the distribution of their chromatin. Agencies which would act
most directly would be those that have the power of destroying definite chromo-
somes.of a cell, while leaving the others uninjured." Boveri, therefore, saw quite
distinctly that irrespective of the mechanism of origin, the disturbed chromatin
content is the essential feature in cellular physiology, including the abnormal
condition of a tumorous growth. The presence ofmultipolar and other abnormal
mitotic figures in tumours and cancers had been investigated previously by
von Hansemann (1890, 1891a, b). Von Hansemann had used thLese observations
in the origin of his concepts ofproopai/a and anaplMsia. The pleomorphism
of cancer cells and the irregular atypical mitoses so characteristic of their nuclei
had been observed and carefully studied, however, since the middle of the
nineteenth century.
Whitman (1919) wrote a critical review of von Hansemann's theory of aiia-
plasia intheorigin ofcancer in terms ofmoderngenetics. Tyzzer (1916) expressed
the opinion that a somatic mutation may be involved in the origin of cancer.
Tyzzer stated, "There are marked differences in the behaviour ofvarious tumours
on transplantation in given classes of mice. Even tumours arising in homo-
geneous races show such differences, and this may be attributed to the acquisition
of new characteristics by the soma which are manifested in the development of
the tumour. The tumour, since it breeds true with respect to these characteristics
in the course of artificial propagation, may be regarded as a modification of the
somatic tissue which may be termed somatic mutation."
At the present time it may be well to indicate two aspects of the genetic
problem in relation to the origin of cancer. These are (1) susceptibility and
resistance to the spontaneous, the transplanted and the induced tumour-an
inherited constitutional state or states in which the germ plasm is definitely
involved, and (2) the origin of the neoplastic lesion by a conversion, somehow or
other, from a pre-existing normal somatic tissue-a somatic mutation. This
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actual process of somatic mutation may either be conditioned or under the
control of an inherited or germinal influence, or entirely independent of such
intrinsic determination. This distinction between the intrinsically determined
susceptibility and resistance to cancer and the somatic origin by mutation is not
always kept clearly in mind. As a matter of fact some investigators express the
opinion that tb.e two genetic phenomena are entirely antagonistic to each other.
For example, a very recent article by Bauer (1948) of Heidelberg discusses at
length that susceptibility to cancer in the human population is not inherited,
and at the same time elaborates on the development of the concept that cancer
arises as a somatic mutation. Bauer states, "The decisive importance ofinherited
characteristics which give rise to cancer is entirely disproved by the experiment
of nature with the hereditarily identical and the hereditarily different fraternal
twins." Bauer has been interested in the somatic mutation hypothesis for
many years, having published his first article in 1928 (Bauer, 1928). Bauer
(1948) concludes, "Thus the mutation theory of tumour development is an inter-
pretation of all cancer phenomena adequate for the clinical, morphological,
biochemical, and in particular genetical facts." A similarly expressed conflict
between the germ plasm and the somatic mutation idea is expressed by Dunning,
Curtis and Bullock, in which they arrive at the opposite conclusion in their
extensive studies of induced sarcomas in the livers ofrats, in that they conclude
that susceptibility to the sarcoma condition is inherited, but that an ill-defined
somatic mutation may also be involved in the origin of the lesion. This
antagonism is, however, not as sharp as would be indicated by the title of their
paper, "The Respective Roles of Heredity and Somatic Mutation in the Etiology
of Tumors Induced by Parasites and Chemical Irritants' (Dunning, Curtis and
Bullock, 1937). In 1933 these investigators had concluded: "Possibly when
more is known about the etiology of other tumours for which there appears to be
an inherited susceptibility and when the expression of genetic factors in the cells
and tissues is better understood, it will be found that in the case ofall neoplasms
in all species the initial cell change occurs by a process analogous to somatic
mutation, and that heredity factors determine this change only in so far as they
influence longevity and the susceptibility ofan individual to some specific irritant
or condition which is favourable to mutation" (Curtis, Dunning and Bullock,
1933, 1934).
Their idea of the nature of this somatic mutation process in the origin of
canceris similar to the one expressed originally by Strong in 1926,whoconcluded:
"This mutational process may be either a change or shifting of a complete
chromosome or chromosomes, or a change or changes within a chromosome or
chromosomes (genic), or it may be even cytoplasmic in nature. By mutation
I merely mean to use the term in its broadest sense, that is, a change or shift
within the genetic or internal constitution that results in definitely clear-cut or
discernible differences in behaviour or structure that are perpetuated by the
process of heredity (in this case, cell division)." (Strong, 1926a, b). That a ten-
dency to undergo somatic mutation may have a definite genetic basis in normal
tissues has been discussed by East (1917). This phenomenon has been encoun-
tered especially in plants, but also has been reported in the higher animals.
An early example of a genetic influence on somatic mutations is discussed by
Whitman (1919). He states, "A somewhat different condition is presented by
the 'bud variations' occurring in plants, and consisting in the production of
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-unlike flowers on different branches of the same plant, e.g. a yellow chrysan- themum carrying white flowers on one branch. It is obvious that, since the
colour of the flower is known to depend on definite factors, the development of a
branch carrying flowers of a colour different from that of the flowers on the
other branches could only arise through the failure of the factors to pass over,
during mitosis, into the cell from which that branch developed. The branch, in
other words, represents a somatic mutation due to asymmetrical mitosis." Many tumours have been described in a variety of genetic material. Many
of these tumnours are pigmented and occur especially in the early development
of the individual, and some are associated with or are identical to lethal muta-
tions. These have been recorded by Stark and Bridges (1926), Wilson (1924) and others in drosophila, by Federly (1936) in lepidopterous larvae, and by
many other investigators. Most of these tumours are inherited by a multiple
factor complex and, in the opinion of T. H. Morgan, expressed to the author
many years ago, at least one of the drosophila tumours arose as a mutation.
Time alone prevents the further discussion of this interesting genetic material
and its bearing on the somatic mutation hypothesis.
The next advance in the somatic mutation idea in relation to neoplastic
lesions was undertaken by the present author, in 1918. From that time onward
until 1930, a considerable amount of evidence was accumulated from the study
of the transplantation of adenocarcinomata of the mammary gland in mice
that eventually provided the first experimental evdence that a somatic mutation
may be involved in the origin of cancer (Strong, 1926a, b). Some of these data
have been published, but a considerable amount has not. The development
ofthis experimental approach to the nature ofthe origin of cancer was as follows:
Tyzzer and Little investigated the transplantation of a sarcoma that originally
arose in a Japanese waltzing mouse. They found that the progressive growth of this transplantable tumour was dependent upon thesimultaneous presence of
multiple mendelizing units (from 12-14). Strong and Little, in 1920, and later
in 1924, determined that two transplantable adenocarcinomata of the mammary
gland in mice were dependent upon different genetic complexes for their continued
growth. The dBrBtumour was dependent upon the simultaneous presence of
two genes, whereas the dBrA tumour was dependent upon the simultaneous
presence of these same two genes, but required the presence, in the host, of a
third gene. The presence of the third gene had no detectable influence on the
growth of the dBrBtumnour. This genetic similarity and difference was obtained
in the same series of mice in spite of the fact that the two tumours were histo- logically indistinguishable (Strong andLittle, 1920; Little and Strong, 1924).
The opinion of identical diagnosis was given by the late Dr. James Ewing, as
well as by Prof. Francis Carter Wood. Upon this evidence, and more of a similar
nature that wassoon obtained, the genetic theory for the transplantation of tumorous tissue was formulated in 1924. The original statement was that "the
fate of the implanted tumour tissue when placed in a given individual (host) is
brought about by a reaction between the host, determined to a large extent by the
genetic constitution, and the transplanted tumour cell, controlled to some extent
by its genetic constitution." The next experiment that advanced this genetic
concept of the nature of cancer was obtained by the author and published in two
papers (Strong, 1926a, b). This observation was the obtainment of sudden sharp
changes in the transplantability, an increased growth rate, and, eventually,
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invasive and metastatic capacities of the same transplantable tumour. The
phenomenon of sudden change occurred many times while the problem was
being investigated, but only one illustration will be given here. A third spon-
taneous tumour that arose in a dilute brown mouse (given symbol dBrC) provided
evidence that six genes were involved originally in the growth of this tumour
when transplanted into a series of suitable F2 individuals derived from a cross
between mice of the dilute brown stock and mice of a totally unrelated stock,
the well-known A stock. Growth rates on the various transplantable tumours
derived from the dBrC tumrour were determined. After several transplant
generations a tumour was obtained that grew so rapidly that it was considered
out ofthe normal range ofgrowth for the original transplantable tumour. When
the derivedtransplant was tested it wasfound that now its growth was dependent
upon the simultaneous presence of only two genes. This sudden acquirement of
growth capacity also resulted consequently in a new transplantability charac-
teristic. Thus the action of four genes in the genetic constitution of the host
were no longer necessary for the successful transplantation of the tumour. A
second sudden change subsequently took place, and a new derived (mutant)
type of tumour would now grow in 75 per cent of all inoculatedF2 mice (observa-
tion 75-00 +: 23-00- ± 2-79). Theprobableerrordifferencebetweenthisnewratio
and the actualobservationforthe originaldBrC tumourwas 58-13 per cent ± 3'67
or 15-84 x P.E. This new derived transplantable tumnour continued to give a
3:1 ratio in a series of F2 mice for several transplant generations. Eventually
a new sudden change took place at which time the-new mutant type grew in
practically all F2 mice (observation 243'00 +: 2-00- 4 0'94). These new data
in the F2 deviated from the ratio obtained with the original dBrC tumour as
follows: 80-78 per cent ± 2-48 or 32-57 x P.E. There can be no doubt that
sudden genetic changes are taking place somewhere in the relationship between
the host and the transplanted tumour. Since the mutant types and the original
transplantable tumour were being compared in the same series ofF2 mice, these
sudden changes could not be taking place in the host but must be taking place
within the tumour cell (Strong, 1926a, 1926b). Another point that should also
be emphasized is the fact that when the derived mutant transplantable tumour
would grow in all F2 mice derived from a cross between the dilute brown and the
A stocks, then, and not till then, would it grow in all mice irrespective ofgenetic
relationship. In other words, it had lost all characteristics of tissue specificity.
The transplanted tumour would grow invasively at a tremendous rate and would
metastasize extensively. Thus evidence was obtained that a highly specific,
relatively benign, slow-growing transplantable tumour had progressively and
suddenly acquired periodically new biological characteristics until finally it had
been converted over into a carcinoma. The early sudden changes in the trans-
plantability of the tumour were not accompanied by any changes in histological
appearance. Toward the end of the series, however, especially at the terminal
non-specific state, the tumour had become more cellular and had lost most of its
original adenocarcinomatous arrangement.
Another series of investigations was performed on the transplantation of the
13 spontaneous tumours that mouse F1 79 gave rise to. This mouse was not
onlythe common ancestor of the well known C, C3H, CBA, C121 and CHI strains
of inbred mice, but also gave rise to a wealth of neoplastic tissue as follows:
All 13 of her spontaneous tumours of mammary origin were tested out by trans-
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plantation in a series of suitable related mice. The data obtained from the study
of two of these tumours, FjDa and F1Dg alone, have been published (Strong,
1929). Thus, in a series of mice that had been injected with both tumours,
one in the left axilla, the other in the right axilla, the data were obtained as
shown in Table I.
TABLE I.-Tumour Reaction.
Number of + G+A. re.G+A. re.Gre.A. -G+A. G-A.
individuals 235 . 76 . 77 . 115 . 347
+ indicates the progressive growth of the transplantable tumour until the death of the mouse,
re. indicates temporary growth followed by comFlete regression, and - indicates complete resistance
to the transplant.
Thus it is evident the two transplantable tumours were giving a different
reaction when transplanted into the same series of mice. There were similarities
ofreaction, however, as well as differences. Some micewould grow both tumours
progressively, whereas other mice would refuse to grow either, and some showed
temporary growth of both tumours. But in the same experiment it was found
thatalargeseries of 76 mice would show only atemporarygrowth ofthe Gtumour
but a progressive growth of the A tumour, and another group of 115 mice would
refuse to grow the G tumour but would grow the A tumour. Further data
obtained from the transplantation of these two tumours (FLDa and FjDg) are
given in Table II.
TABLE II.-Tunour Reaction.
+G. +A. -G. +A. -G. -A. Total.
Sex . . . . . l .
Originalnegativestrain 0 0 . 0 0 . 46 40 . 46 40
Orig. F1 neg. Y x + G
+A . . . 52 0 . 0 48 . 0 0 . 52 48
F2 from above . . 85 82 . 78 82 .228 222 .391 386
F1 G Aorig. neg. 36 30 . 0 0 . 0 0 . 36 30
F2 from above . .102 48 . 0 51 .140 134 .242 233
The study of these two tumours derived from the same mouse produced data
that permitted the following conclusions. The two tumours, even in spite of the
fact that they were derived from the same individual and were histologically
indistinguishable, were indeed quite different. They were physiologically
different, and presumably genetically different also. If one assumes, for the
sake of argument, that one of these tumours possesses the same genetic consti-
tution as the mouse tissue from which it arose, then the other tumour tissue
cannot have it. This assumption is a valid one, since the recent interpretations
of histogenesis would lead us to the conclusion that qualitative cell-divisions
probably do not occurin animate forms. Every cell ofthe adult body is supposed
to be endowed with the same genetic potentialities. Since, therefore, one of
the tumours must have a different genetic constitution from the mouse tissues
from which it has originated, it must have deviated, presumably by some such a
102INDUCTl10N OF MUTATIONS BY CARCINOGEN
process as somatic mutation, from the genetic constitution of the somatic tissue
from which it arose. And if one tumour tissue has deviated from the genetic
constitution of the somatic tissue from which it arose, then possibly all tumours
undergo the same process in their origin.
The above phenomena especially of sudden changes taking place during
the transplantability of spontaneous adenocarcinomas of the mammary gland
in mice has been amply verified, not only by the investigation of the 11 other
tumours derived from female F179 referred to previously, but also by many other
tumours derived from other mice in my laboratory. All the phenomena of
transplantation consistent with the genetic theory of transplantation were also
verified by the independent work of Bittner (1931) and by Cloudman (1932a, b).
Eight years later Little (1934) wrote a review on the genetic work on the trans-
planted tumour in mice in which he included a discussion of the somatic mutation
idea. In this paper Little points out that he had outlined the genetic basis for
susceptibility and nonsusceptibility to transplanted tumours in 1914 (Little,
1914). He states again in 1934 that "The bit oftumnour tissue to be transplanted
has a genetic composition, which is determined by that of the animal in which it
arises." If this idea was exclusively true, then it is obvious that a somatic
mutation could not have been involved in its origin since any mutational process
should alter or change the original genetic state. It is indeed true that in the
early transfer generations, the transplanted tumour derived originally from a
spontaneous source does retain the characteristic of tissue specificity determined
by the genetic constitution of the mouse, in- that it will grow only inindividuals
which are genetically related to the mouse that gave rise to the tumour. But it
has now been definitely proven that this phenomenon of tissue specificity is
periodically and progressively lost by sudden changes resulting in simpler and
simpler mendelian ratios, until eventually the tumour retains no or very little
tissue specificity which it originally had. These sudden or mutational changes
have always produced more and more malignancy, as determined by percentage
of takes, growth rate and eventual invasive and metastatic characteristics. It
has also been indicated that no two tumours, even though they be derived from
the same mouse and present the same histological appearance, ever showed the
same mendelian ratio when transplanted into a series of appropriate F2
individuals. When two transplantable tumours were derived from-the same
mouse, some of the genetic complex involved in their successful transplantation
is common to both tumours, whereas some are unique to either the one or the
other tumour. Similarity of genetic transplantability complex indicates genetic
relationship of origin for tumours. In this particular Little's concept of 1914 is
therefore partially correct. It is also evident that the more recently chemically-
induced tumours show, from their very origin, on an average, more malignancy,
and thus less tissue specificity than do the spontaneous tumours that arise in
thesame series ofinbred or hybrid mice. It is probably true, although at present
impossibleofproof, that there is some genetic mechanism within cells that deter-
mines to some extent normal cell relationship, but that under certain conditions
this controlling genetic mechanism alters or changes, and by so doing permits
an uncontrolled or cancerous- condition to arise somewhere in the biological
system (the organism). This phenomenon of break of co-ordinating influence of
a definitive part is, I believe, the essential feature in the origin of cancer. The
fact that the tumour or cancer grows progressively is of secondary importance,
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following the experimental evidence reported by Strong (1926a, b), and verified
later by Bittner (1931) and by Cloudman (1932a, b).
Little (1941) stated the problem in different terms from those he used in 1914.
Henowstates: "In accepting as a working hypothesis the statement that cancer
ilfils the requirements of a somatic mutation, namely, a sudden change which is
perpetuated in succeeding cell generations, it must be noted that there are already
on record two distinct general types of somatic mutation, either ofwhich might
be involved in the appearance of cancer. One of these is the result of internal
environmental change directed by one or more genes. The other has a sporadic
etiology dependent on various influences which affect individual cells or groups
of cells directly. In the first category belong such cases as mutations in colour
genes in rodents described by Castle, Pincus, Bittner and others. One ofCastle's
cases is particularly interesting in that it shows several cases of mutations occur-
ring in several generations of a single family ofrabbits, thus indicating a definite
genetic basis. Cases of the second type have been recorded as the result of
exposure to radio-active agents." Lockhart-Mummery (1934) has published a
book on mutations and cancer, and there have been several other articlesdealing
with this problem. These cannot be discussed at this time.
The disovery that carcinogenic compounds can induce mutations when
injected into suitable experimental animals has not originated the idea that cancer
may arise by a process of somatic mutation, but rather has reopened interest in
an old concept. The essential features of the historical development of this
mutation concept have been outlined above. The problem has been discussed
by many investigators. Some experimental evidence, although of an indirect
nature, has been obtained, and it is clear that there is no evidence contrary to
such a somatic mutation concept. The first criticism of such a concept that
cancer may arise by some such a mutational process was expressed to me more
than 25 years ago by a very distinguished geneticist, who stated that "you
cannot prove that cancer arose from somatic tissue through the process of
somatic mutation because you cannot hybridize cancer tissue to normal tissue
from which it arose." It is indeed gratifying that in the last issue of Sigma XI
quarterly this samedistinguished geneticist (Sturtevant, 1948) has now expressed
the opinion that the indication of a gene can be determined by a method other
than by the process of hybridization.
A different biological interpretation of the evidence bearing upon the origin
of neoplastic growths has been expressed by Dahlberg (1940). He states that
"if tumours are regarded as descendants of a cell which has undergone mutation,
it is understandable that tumour cells should show features differing from what
is normal. Possibly we may also understand the autonomous character of the
tumour tissues. On the other hand, the somatic-mutation theory hardly explains
the embryonic features of malignant tumours; and it does not explain why
growths are more frequent in older than in younger individuals, because it has
not beenobserved that mutations in cells ofthe gonads are more frequent in older
than in younger persons. Nor does it help us to understand why external stimu-
lation should give rise to tumours, though it is possible to suggest more or less
plausible analogies. Thus X-ray treatment may give rise to formations of
tumours in the cells of the body and to mutations in the germ cells. A detail of
particular interest is the occurrence of abnormalities among the chromosomes
both in cells which have undergone mutation and in tumorous cells. The muta-
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tiontheoryexplainscertainfeaturesof the tumours, but leaves other andessential features unexplained. If we want to explain the genesis ofmalignant tumours with the help ofanalogies to known biological phenomena of more general occur- rence, it seems to the writer that another possibility lies nearer to hand; and it is the object of the ensuing discussion to indicate the possibility of exploring some
conclusions suggested by following out its consequences. The development
of tumours may be compared to vegetative reproduction." Whether the concept ofvegetative reproduction will explain more phenomena concerning the origin of cancer than does the somatic mutation idea should
perhaps be more fully discussed. This cannot be done at the present time. Theinduction ofmutations by carcinogens has led to the conclusion that"all carcinogens aremutagens and all mutagens are carcinogens." This expression has been used by the present author, by Dr. Demerec, and very recently byProf. Bauer of Heidelberg. It is the purpose of this paper to analyse the present status of the problem in order to see whether this conclusion should now be
accepted or discarded. Germinal mutations and other biological variants induced by carcinogenic compounds have been reported in mice by Strong and by Carr. Hollander,
working in my own laboratory, has also obtained similar results following the intraperitoneal injection of methylcholanthrene into pregnant mice that had been outcrossed to males of other inbred strains. This procedure of Hollander has induced germinal mutations which appeared for the first time in mice of the ensuing untreated F3 generation. Prof. Tatum of Yale has also obtained a few
mutations in neurospora with a derivative of methylcholanthrene and concludes
that, in this species, methylcholanthrene is a mild-mutagen. Dr. Demerec has
reported data obtained on mutagenesis with many carcinogens and closely related non-carcinogenic chemicals in drosophila. According to him these compounds
haxe been studied in conjunction withaerosol and other detergents. By this
means he has reported many mutations (notably sex-linked lethals) with the
carcinogenic hydrocarbons, and has stated that he has obtained a few chromosome
breaks in his experimental material. It is an established fact that the term
mutagenic is not an absolute characteristic for any physical or chemical agent. For example, it may be said that X-rays are a powerful mutagen. They are very effective in inducing mutations in drosophila and in neurospora, and to
acertain extent in maize, but do so very poorly in mice. On the other hand,
ultra-violet light appears to be more effective in inducing mutations in maize
than in drosophila. Again it must be taken into consideration that the different physical and chemical agentsbring about mutations in various ways. X-rays
break chromosomes, thus leading to rearrangements of parts, transpositions
and inversions, to deletions, etc. Ultra-violet light, however, seems more
effective in inducing point mutations in both corn and drosophila, possibly by providing a specific wave-length,2600°, that is selectively absorbed by the nucleo-
proteins of the chromosomes. We have so far obtained no evidence that methvl-
cholanthrenewill break chromosomes or bring about any chromosomal aberration
in mice. All the mutations so far tested have been proven to be "point muta- tions." This phenomenon is of significance, since Burrows has shown that the carcinogens will cause chromosomes in
growing
root tips tolag on the spindle,
thus indicating a mechanism ofnon-disjunction or other chromosomal aberrations
to take place. The present author has obtained several possible disturbances in
105L. C. STRONG
sex ratios and in distorted mendelian ratios which may be later proven to be
chromosomal, but so far all mutations induced by methylancholthrene in mice
which have been tested have been proven to be point mutations. Finally, the
mustard gas derivatives, the fourth group of powerful mutagens seem very
effective in breaking chromosomes, producing embryonic disturbances very
similar to the effects of X-rays, but apparently may have another action on
mutagenesis, since they appear to affect cells even before there be any evidence
of cell division (action therefore similar, but possibly different from that obtained
with X-rays).
Carcinogenesis again is a relative rather than an absolute property. The
mouse for some unknown reason is extremely sensitive to give rise to a variety
of neoplastic lesions by any one of a great varietyv of chemicals. On the other
hand, other species are extremely liable to great resistance to experimentally
induced tumours. For example, the rhesus monkeys in New Haven have been
injected with methylcholanthrene for 15 years without producing a single neo-
plastic tumour. One must conclude, therefore, that for this species methyl-
cholanthrene is not a carcinogen, or at least, if it is, the evidence for such a
conclusion is still not available. Even within the species, however, the property
of carcinogenesis is not an absolute one The end-result of the injection of a
possible carcinogen, including the latent period, the survival time and the type
of tumour induced or no tumnour whatever depends upon the vehicle or solvent,
the dose, the mode of introduction, the age of the experimental animal, etc.
But even when all these environmental factors have been standardized, there is
still great variability of results when mice of the various inbred strains are used.
Greater variability of carcinogenesis is obtained when hybridization and selection
are resorted to. Carcinogenesis in mice, therefore, is a variable characteristic.
In the various strains of mice the estimation of carcinogenesis for methylcholan-
threne differs from zero to 4.
It is also a very significant fact that the mouse is the only animate form in
which the characteristics of mutagenesis and carcinogenesis can be compared in
the same species. Briefly stated, therefore, the problem of comparing the
properties of mutagenesis and carcinogenesis for any given group ofphysical and
chemical agents is comparing and contrasting two extremely variable charac-
teristics which differ between different species and even between different indi-
viduals of the same species. The problem is even more complex than this, as
will be indicated in the following discussion.
Not all of the biological variants obtained in mice with methylcholanthrene
are genetic. The present author has tested many of these effects obtained in the
descendants ofmice receiving methylcholanthrene, and is forced to the conclusion
that many results are non-genetic. These variants are not considered to be
non-genetic until they fail to reappear in the double backcross generation to the
variant condition following an outcross to a totally unrelated strain. Another
class offrequent occurrence is the somatic mosaic. These individuals are somatic
composites oftwogenotypes forwhich noevidence ofinheritance can be obtained.
Another class of variants, such as the absence of one ovary alone or together
with the congenital absence of one horn of the uterus is not genetic, and possibly
may be explained in terms of specific inhibitions at particular or critical times
of embryonic morphogenesis. It is a known fact that the carcinogens inhibit
normal growth processes when injected into experimental animals, and there is
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no reason why this process of inhibition may not apply to the development of
the embryo at critical periods of differentiation. The somatic mosaic may be
due to a chromosomal aberration rather than a point mutation in somatic differen-
tiation, although the actual mechanism involved in their origin cannot be deter-
mined.
We have obtained, therefore, a multiplicity ofbiological effects when methyl-
cholanthrene has been injected into a series of mice over many generations.
Whether all these phenomena are due to the original methylcholanthrene or to
one or many ofthe derived metabolites is still not known. Some ofthese effects
are definite point mutations, some are non-genetic, some are non-genetic produced
possibly by inhibitions of embryonic morphogenesis at critical periods, and other
biological effects may have other mechanisms in their origin, such as abnormal
distribution of chromosomes during morphogenesis.
But these mice whose ancestry has been injected with methylcholanthrene
for many generations are not only giving rise to a wealth ofbiological effects, but
also to a great variety ofcancers. At least two genetic effects have been obtained
in relation to induced tumours. The first genetic result was the production of
germinal mutations which changed the rate at which fibrosarcomas appeared at
the site of injection of methylcholanthrene (a decreased latent period). The
second genetic effect was the production of spontaneous lesions involving the
mucus-secreting cells of the gastric mucosa following the induction of this same
gastric lesion from the subcutaneous injection of methylcholanthrene. The
appearance of this specific type of pathological lesion was brought about by a
mutation on the "brown tagged" chromosome. Several new sudden changes
have appeared in the gastric lesion subline changing the latent period for the
appearance of the lesion-a phenomenon that was obtained in the transplan-
tation of adenocarcinomata of the mammary gland in mice and discussed in
this same paper. Whether these new sudden changes are due to specific muta-
tions may eventually be indicated.
The work on chemical carcinogenesis has provided much data of genetic
interest. It appears now that the investigators of cancer can repay their debt
to the investigators of general biology by reversing the process of borrowing
observations in that field and to contribute information bearing on that science.
SUMMARY.
1. Sudden changes occur periodically in the transplantation of cancers in
mice, which result in more malignant conditions by biological or genetic changes
giving simpler and simpler mendelian ratios.
2. No two transplantable tumours ever have given the same mendelian ratio
in the same series ofF2 individuals, even though the tumours were derived from
the same mouse and were histologically indistinguishable.
3. A multiplicity of biological effects have been induced in mice by methyl-
cholanthrene for which different biological mechanisms must be responsible.
4. As a general rule all mutagens are carcinogens and all carcinogens are
mutagens, but exceptions to the rule must be kept in mind.
5. The mouse is the only animal where carcinogenesis and mutagenesis can
be compared in the same species.
6. By accepting the concept that cancer arises from a process of somatic
mutation, a pessimistic attitude for its eventual control is not indicated.
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7. Somewhere in the completely resistant-to-cancer individual, produced or
improved by the genetic process of selection, there must be a resistant-to-cancer
mechanism.
8. When the resistant mechanism has been completely investigated that
determines the biological state of resistance to cancer in all its points, no matter
how great the insult, then this principle (possibly biochemical in nature) must
control cancer in all species.
This experiment has been made possible by grants from the Anna Fuller
Fund and the Jane Coffin Childs Memorial Fund for Medical Research.
REFEREFNCES.
AICimL, O.-(1911) 'Ueber Zellverschmelzungen mit qualitativ abnormer Chromo-
somen verteilung als Ursachen des Geschwulstbil dung. Vortrage u. Auf.
satzeuiiber Entwicklungs mechanik.' Leipzig (W. Engelmann).
BAUE, K. H.--(1928) 'Mutations theorie der Geschwulstenstehung. Ubergang von
K6rperzollen in Geschwulstzellen durch Genanderung.' Berlin (Springer).
Idem.--(1948) 'On the Cancer Problem.' Heidelberg (Springer),
Brrma, J. J.--(1931) Amer. J. Cancer, 15, 2202.
BovExi, T.--(1929) 'The Origin of Malignant Tumors.' Translated by Marcella
Boveri. Baltimore (The Williams & Wilkins Co.), p. 111.
CLOUIDMAN, A. M.--(1932 ) Amer. J. Cancer, 15, 568.--(1932b) Genetics, 17, 468.
CumTIS, M. R., DIrNING, W. F., AND, BuLLOCK, F. D.--(1933) Science, 77, 175.-(1934)
Amer. J. Cancer, 21, 86.
DAruRERG, G.--(1940) Upsala Lakareftreningsf&rhandlingar. Nyfojd., 76, 21.
DUNIN'G, W. F., CRxTIs, M. R., x-oD BULLOCK, F. D.--(1937) Occasional Publication,
Amer. Ass. Adv. Sci., 29.
EAST, E. M.-(1917) Amer. Nat., 51, 129.
FEDERTY, H.-(1936) Hereditas, 22, 193.
LrrIr, C. C.-(1914) Science, 40, 904.-1934) Amer. J. Cancer, 22, 578.--(1941) J.
nat. Cancer Inst., 2, 133.
Idem A.ND STRONG, L. C.--(1924) J. exp. Zool., 41, 93.
ICKART-MUXMERY, J. P.--(1934) 'The Origin of Cancer.' London (J. & A.
Churchill).
MUBRAY, J. A.--(1908) Sc. Rep. Imp. Cancer Res. Fund, p. 69.
STARK, W. B., AN-D BRDGES, C. B.--(1926) Genetics, 11, 249.
STRONG, L. C.-(1926a) Genetics, 11, 294.--(1926b) J. exp. Med., 43, 713.-(1929) J.
Cancer Res., 13, 103.
Idem AND LrrrE, C. C.--(1920) Proc. Soc. exp. Biol., N.Y., 18, 45.
STuTEvRA-RTr, A. H.--(1948) Amer. Sci., 36, 225.
TYZZEE, E. E.--(1916) J. Cancer Res., 1, 125.
VON HAN-sEM-NN.-(1890) Virchows Arch., 119, 299.--(1891a) Ibid., 123, 352.-(1891b)
Ibid., 129, 436.
WmTAn&N, R. C.--(1919) J. Cancer Res., 4, 181.
WILSON, I. T.--(1924) Genetics, 9, 343.